1. Richard S. Garfein, PhD Professor Division of Global Public Health UCSD School of Medicine (April 11, 2014) 2. Objectives  Describe the harms of injection drug use…

Slide 1Dr. E. Anne Peterson, MD, MPH Assistant Administrator, Bureau for Global Health, USAID Sustainable Investment and Donor Coordination Stop TB Partners Forum March 25,…

Slide 1 Molecular Epidemiology Slide 2 This is the principle technique of scientific inquiry: by changing the scale of description, we move from unpredictable, unrepeatable…

Slide 1 Latent Infection of Tuberculosis in China HUASHAN HOSPITAL, FUDAN UNIVERSITY, Shanghai, China Wenhong Zhang, M.D & PhD. Slide 2 TB: A leading infectious killer…

Slide 1 TB 101 Dee Pritschet, TB Controller North Dakota Department of Health September 16, 2014 Slide 2 Objectives Participants will be able to:  1) describe the cause…

Slide 1 T UBERCULOSIS Slide 2 P HYSICAL ILLNESS Physical illness among IDUs is more common as compared to the general population A Study from Chennai conducted in 2005 –…

TB 101 TB 101 Dee Pritschet, TB Controller North Dakota Department of Health September 16, 2014 Objectives Participants will be able to: 1) describe the cause of tuberculosis…

PowerPoint Presentation Effectively screening for Latent TB HIV/STD/TB/Hepatitis Symposium North Dakota April 2012 . Mary Shragal Area Director Sales, Northern Region USA…